GO:0071806 protein transmembrane transport: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071806 protein transmembrane transport is defined as the process in which a protein is transported across a membrane.
• It encompasses both co-translational translocation into the endoplasmic reticulum and post-translational import into organelles such as peroxisomes and mitochondria.
• Transmembrane domains and sorting motifs act as address labels that direct proteins to the correct membrane or organelle.
• Key molecular players include the Sec61 translocon, the GET and PEX import machineries, and retromer components.
• Defects in protein transmembrane transport are linked to cancer, neurodegeneration, and peroxisomal biogenesis disorders.
• CRISPR knockout, knock-in, and overexpression models enable causal testing of transport-related genes in disease contexts.
Description
Protein transmembrane transport (GO:0071806) is the biological process by which a protein is moved across a lipid bilayer membrane. This process is fundamental to cellular organization, enabling proteins synthesized in the cytosol to reach the endoplasmic reticulum (ER), Golgi, lysosomes, peroxisomes, mitochondria, and the plasma membrane. Unlike small-molecule transport, protein transmembrane transport requires dedicated proteinaceous machineries that recognize targeting signals, unfold or thread the polypeptide, and provide a conduit through the membrane. The term is distinct from vesicular transport, which moves proteins between membrane-bound compartments without crossing a bilayer; GO:0071806 specifically covers the crossing step itself. Researchers study this process to understand organelle biogenesis, secretory pathway function, and the molecular basis of diseases caused by mistargeted or stalled transport.
protein transmembrane transport At A Glance
| GO ID | GO:0071806 |
|---|---|
| GO term | protein transmembrane transport |
| Ontology | biological_process |
| Synonym | protein membrane transport |
| Major function | Translocation of proteins across lipid bilayers into organelles or the extracellular space |
| Related processes | Protein targeting, co-translational translocation, post-translational import, endosomal recycling |
| Key cellular sites | Endoplasmic reticulum, peroxisomes, mitochondria, Golgi, lysosomes, plasma membrane |
| Example machineries | Sec61 translocon, GET complex, PEX import machinery, retromer |
What Is GO:0071806?
According to the Gene Ontology, GO:0071806 protein transmembrane transport is the process in which a protein is transported across a membrane. This definition captures the directed movement of a polypeptide from one side of a lipid bilayer to the other, whether the protein remains soluble in the target compartment or becomes integrated into the membrane. The synonym protein membrane transport is also used. The term is a biological process and should not be confused with vesicle-mediated transport or with the transport of individual amino acids.
Why Is protein transmembrane transport Important in Cell Biology?
Protein transmembrane transport is essential for nearly every aspect of eukaryotic cell biology, from the biogenesis of secretory and membrane proteins to the maintenance of organelle function. Defects in this process cause a wide range of human diseases, including peroxisomal biogenesis disorders, neurodegenerative conditions, and cancer. Understanding the molecular rules that govern transmembrane transport also informs the design of therapeutic proteins and the interpretation of disease-associated mutations.
• Enables delivery of secretory and membrane proteins to their correct destinations.
• Required for peroxisomal import of matrix enzymes involved in lipid metabolism.
• Underpins lysosomal enzyme targeting and function.
• Supports endosomal receptor recycling and cell surface homeostasis.
• Mutations in transport machinery components cause peroxisome biogenesis disorders.
• Altered transport contributes to cancer cell survival and drug resistance.
• Provides targets for antiviral and antiparasitic drug development.
• Essential for plant cell wall and stress responses.
• Facilitates protein secretion in biotechnology and biopharma.
• Links to autophagy and lysosomal degradation pathways.
What Happens During protein transmembrane transport?
Signal recognition and targeting
In simple terms: The cell reads a zip code on the protein to decide where it should go.
The first step in protein transmembrane transport is the recognition of a targeting signal within the nascent polypeptide or the mature protein. For proteins destined for the endoplasmic reticulum (ER), an N-terminal signal peptide or a transmembrane domain is recognized by the signal recognition particle (SRP), which pauses translation and delivers the ribosome-nascent chain complex to the ER membrane. In plant cells, similar signal-based targeting mechanisms operate for Golgi and vacuolar proteins. For peroxisomal matrix proteins, a C-terminal peroxisomal targeting signal 1 (PTS1) or an N-terminal PTS2 is recognized by soluble receptors PEX5 or PEX7, respectively.
Membrane translocation
In simple terms: The protein is threaded through a channel that crosses the membrane.
Once targeted, the protein must cross the lipid bilayer. In the ER, the Sec61 translocon forms an aqueous channel that allows the polypeptide to pass through the membrane. Soluble proteins are fully translocated into the ER lumen, while membrane proteins are integrated into the bilayer via lateral opening of the translocon. Peroxisomal matrix proteins are imported post-translationally through a transient pore formed by PEX5 and other peroxins; the receptor is subsequently recycled to the cytosol. In endosomes, retromer mediates the retrieval of transmembrane receptors from endosomes to the trans-Golgi network, a process that requires crossing of the endosomal membrane.
Folding and quality control
In simple terms: After crossing, the protein is checked for correct shape before it moves on.
Following translocation, proteins undergo folding and quality control. In the ER, chaperones such as BiP and the calnexin/calreticulin cycle ensure that only properly folded proteins proceed to the Golgi. Misfolded proteins are retro-translocated to the cytosol for degradation by the proteasome, a process that also requires crossing the ER membrane. In peroxisomes, imported enzymes fold in the cytosol and are imported in a folded or even oligomeric state, a unique feature of this transport pathway. Lysosomal enzymes are tagged with mannose-6-phosphate and transported via the endosomal system, where retromer contributes to receptor recycling.
Vesicular delivery and recycling
In simple terms: The protein is packaged into bubbles that carry it to its final stop.
After transmembrane transport into an organelle, many proteins are further delivered by vesicular carriers. For example, proteins that have entered the ER are transported to the Golgi and then sorted to the plasma membrane, lysosomes, or secretory vesicles. Retromer and actin-dependent mechanisms mediate the recycling of receptors from endosomes back to the Golgi or plasma membrane, ensuring that transport machineries are not depleted. In plants, motif-based endomembrane trafficking directs proteins to vacuoles or the apoplast. Defects in these steps lead to accumulation of proteins in the wrong compartment and can trigger disease.
Key Genes Involved in GO:0071806 protein transmembrane transport
The following genes and proteins are central to protein transmembrane transport, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SEC61A1 | Core channel of the ER translocon | Studied for co-translational translocation and ER quality control |
| SRP54 | Signal recognition particle subunit | Targets nascent chains to the ER membrane |
| PEX5 | Peroxisomal matrix protein receptor | Essential for peroxisomal import; mutated in peroxisome biogenesis disorders |
| PEX7 | Peroxisomal PTS2 receptor | Recognizes PTS2 signals; defects cause rhizomelic chondrodysplasia punctata |
| VPS35 | Retromer component | Mediates endosomal receptor recycling; linked to Parkinson's disease |
| VPS26 | Retromer component | Forms cargo-selective complex with VPS35 |
| VPS29 | Retromer component | Required for retromer stability and function |
| TMEM87A | GOLD-domain seven-transmembrane protein | Structural studies reveal membrane topology and potential transport roles |
| SNX1 | Sorting nexin, retromer-associated | Binds phosphatidylinositol 3-phosphate for endosomal sorting |
| SNX2 | Sorting nexin, retromer-associated | Participates in endosomal carrier formation |
| RAB7A | Late endosomal GTPase | Regulates endosomal maturation and transport |
| ACTB | Actin cytoskeleton component | Actin-dependent endosomal recycling |
| LAMP1 | Lysosomal membrane protein | Marker for lysosomal transport and function |
| CTSD | Lysosomal aspartyl protease | Model cargo for lysosomal transport studies |
| M6PR | Mannose-6-phosphate receptor | Directs lysosomal enzymes from Golgi to endosomes |
| COG3 | Conserved oligomeric Golgi complex subunit | Golgi trafficking and glycosylation enzyme transport |
| BET1 | Golgi SNARE | Mediates intra-Golgi and ER-Golgi transport |
How Is protein transmembrane transport Regulated?
Protein transmembrane transport is regulated at multiple levels. Transcriptional control of transport machinery components adjusts capacity in response to cellular demand. Post-translational modifications, such as phosphorylation of retromer subunits, modulate endosomal recycling. In plants, hormonal signals and stress conditions alter the expression of trafficking-related genes. The peroxisomal import cycle is regulated by ubiquitination and recycling of PEX5. Additionally, quality control pathways in the ER sense the folding status of transported proteins and adjust translocation rates accordingly.
protein transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PEX5 | Peroxisome biogenesis disorders (Zellweger syndrome) | CRISPR knockout in human fibroblasts; peroxisomal import assay |
| VPS35 | Parkinson's disease; endosomal recycling defects | Knock-in of disease-associated mutation; neuronal cultures |
| CTSD | Lysosomal storage and cancer | Overexpression and knockout in cancer cell lines; lysosomal transport assay |
| TMEM87A | Membrane protein trafficking; potential cancer link | Knockout and tagged knock-in for localization studies |
| COG3 | Congenital disorders of glycosylation | CRISPR knockout in HEK293; Golgi transport assays |
Peroxisomal biogenesis disorders
Mutations in PEX genes that mediate peroxisomal protein import cause a spectrum of diseases, including Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease. These disorders are characterized by defective import of peroxisomal matrix enzymes, leading to accumulation of very-long-chain fatty acids and neurological impairment. Experimental models using patient fibroblasts and CRISPR knockout of PEX5 or PEX7 have been used to study the transport defect.
Neurodegeneration and retromer dysfunction
The retromer complex, which mediates endosomal receptor recycling, is implicated in Alzheimer's disease and Parkinson's disease. Reduced retromer function leads to accumulation of amyloid precursor protein (APP) and altered trafficking of neuronal receptors. Actin-dependent endosomal recycling defects further contribute to synaptic dysfunction. Knockout and knock-in models of VPS35 have been used to dissect these pathways.
Cancer and lysosomal transport
Altered lysosomal protein transport supports cancer cell survival by promoting autophagy and drug resistance. Lysosomal enzymes such as cathepsin D require proper mannose-6-phosphate receptor-mediated transport; defects can lead to altered lysosomal function and tumor progression. Experimental models include lysosomal transport assays and CRISPR knockout of M6PR or LAMP1.
Plant development and stress
In plants, protein transmembrane transport is essential for cell wall biosynthesis, hormone signaling, and stress responses. Mutations in Golgi trafficking components affect root growth and pathogen defense. These processes are studied using Arabidopsis mutants and motif-based trafficking reporters.
From protein transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for ER translocation? | CRISPR knockout of SEC61A1 or SRP54 in HEK293 cells |
| Does a mutation in PEX5 affect peroxisomal import? | Point mutation knock-in of patient variants in fibroblasts |
| How does VPS35 mutation affect endosomal recycling? | Knock-in of VPS35 D620N in neuronal cells |
| Where does TMEM87A localize? | Tagged knock-in with fluorescent protein |
| Can overexpression rescue transport defects? | Overexpression of wild-type PEX5 in patient cells |
| What is the role of retromer in lysosomal transport? | Knockout of VPS26 or VPS29 in HeLa cells |
How to Study the protein transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Localization and dynamics of transport proteins | Tracking ER-to-Golgi transport |
| In vitro translocation assay | Efficiency of protein import into organelles | ER and peroxisomal import studies |
| Subcellular fractionation | Distribution of proteins among organelles | Lysosomal transport analysis |
| Co-immunoprecipitation | Protein-protein interactions in transport complexes | Retromer complex assembly |
| Mass spectrometry | Identification of transport machinery components | Interactome of Sec61 or retromer |
| CRISPR knockout screen | Genes required for transport | Discovery of novel PEX genes |
| Live-cell imaging | Real-time movement of cargo | Endosomal recycling dynamics |
| Motif prediction bioinformatics | Sorting signals in protein sequences | Plant endomembrane trafficking |
Fluorescence microscopy and live-cell imaging
Fluorescence microscopy allows visualization of protein transport in real time. Tagged cargo proteins and organelle markers can be used to track movement from the ER to the Golgi or from endosomes to the plasma membrane. Live-cell imaging of retromer components has revealed the dynamics of endosomal recycling. In plants, fluorescent reporters have been used to study Golgi and vacuolar transport.
Biochemical transport assays
In vitro translocation assays using microsomes or purified organelles measure the efficiency of protein import. Peroxisomal import can be assayed by monitoring the maturation of PTS1-containing reporters. Lysosomal transport is assessed by measuring the delivery of cathepsin D or other enzymes to lysosomes. These assays are often combined with subcellular fractionation and immunoblotting.
Proteomics and interactomics
Mass spectrometry-based proteomics identifies proteins that co-purify with transport machineries. Affinity purification of Sec61 or retromer complexes followed by mass spectrometry has revealed interacting partners. Proximity labeling approaches can map the spatial organization of transport pathways. These methods are complemented by bioinformatics analysis of sorting motifs.
Genetic screens and CRISPR libraries
Genome-wide CRISPR knockout screens have been used to identify genes required for protein transmembrane transport. For example, screens for peroxisomal import defects have uncovered novel PEX genes. Retromer-dependent recycling can be screened using fluorescent cargo reporters. These screens are powerful for discovering new components and disease modifiers.
How CRISPR Can Be Used to Study GO:0071806 protein transmembrane transport
Knockout
CRISPR knockout is used to eliminate genes involved in protein transmembrane transport, such as PEX5, VPS35, or SEC61A1, to assess their requirement for cargo import. Knockout cell lines can be generated in HEK293, HeLa, or patient fibroblasts and validated by immunoblotting and functional transport assays. These models are essential for distinguishing essential from redundant components.
Point Mutation
Point mutation knock-in introduces disease-associated variants, such as VPS35 D620N or PEX5 missense mutations, to study their impact on transport. CRISPR-based base editing or homology-directed repair can create isogenic lines for precise comparison. These models help link genotype to transport dysfunction.
Knock-in
Knock-in of fluorescent or epitope tags allows visualization and purification of transport proteins at endogenous levels. Tagged knock-in of TMEM87A or retromer subunits enables live-cell imaging and proteomics. This approach avoids artifacts from overexpression and preserves regulatory context.
Overexpression
Overexpression of wild-type or mutant transport proteins can rescue or exacerbate transport defects. For example, overexpression of PEX5 can restore peroxisomal import in patient cells. Overexpression of retromer components can enhance endosomal recycling. These models are useful for structure-function studies and drug screening.
How EDITGENE Supports protein transmembrane transport Research
Researchers studying protein transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in a specific transport step or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for protein transmembrane transport research.
Frequently Asked Questions About protein transmembrane transport
What is GO:0071806 protein transmembrane transport?
GO:0071806 is a Gene Ontology biological process term defined as the process in which a protein is transported across a membrane.
What genes are involved in protein transmembrane transport?
Key genes include SEC61A1, SRP54, PEX5, PEX7, VPS35, VPS26, VPS29, and TMEM87A, among others.
How is protein transmembrane transport different from vesicular transport?
Protein transmembrane transport involves crossing a lipid bilayer, whereas vesicular transport moves proteins between compartments without crossing a membrane.
What diseases are linked to defects in protein transmembrane transport?
Peroxisomal biogenesis disorders, Parkinson's disease, Alzheimer's disease, and some cancers are linked to transport defects.
What is the role of the Sec61 translocon?
The Sec61 translocon forms a channel in the ER membrane that allows proteins to cross during co-translational translocation.
How do PEX5 and PEX7 function in peroxisomal import?
PEX5 and PEX7 are receptors that recognize peroxisomal targeting signals and mediate protein import into peroxisomes.
What is retromer and how does it relate to protein transmembrane transport?
Retromer is a protein complex that mediates endosomal receptor recycling, a process that involves transmembrane transport of cargo receptors.
Can CRISPR be used to study protein transmembrane transport?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to study genes involved in protein transmembrane transport.
What methods are used to measure protein transmembrane transport?
Fluorescence microscopy, in vitro translocation assays, subcellular fractionation, and proteomics are commonly used.
What is the clinical relevance of protein transmembrane transport research?
Understanding this process informs the development of therapies for peroxisomal disorders, neurodegeneration, and cancer.
Conclusion
Protein transmembrane transport (GO:0071806) is a fundamental biological process that ensures proteins reach their correct subcellular destinations. The integration of genetic, biochemical, and imaging approaches has revealed the molecular machineries and regulatory mechanisms that govern this process. Dysregulation of transmembrane transport contributes to a range of human diseases, making it a critical area for therapeutic intervention. Continued research using CRISPR-based models and advanced screening technologies will further illuminate the transport code and its role in health and disease.
References
- 1. Cosson P et al.. 2013. Anchors aweigh: protein localization and transport mediated by transmembrane domains.. Trends Cell Biol 23(10):511-7 PMID: 23806646
- 2. Bonifacino JS et al.. 2008. Retromer.. Curr Opin Cell Biol 20(4):427-36 PMID: 18472259
- 3. Hoel CM et al.. 2022. Structure of the GOLD-domain seven-transmembrane helix protein family member TMEM87A.. Elife 11 PMID: 36373655
- 4. Arora D et al.. 2021. Motif-based endomembrane trafficking.. Plant Physiol 186(1):221-238 PMID: 33605419
- 5. Francisco T et al.. 2017. Protein transport into peroxisomes: Knowns and unknowns.. Bioessays 39(10) PMID: 28787099
- 6. Simonetti B et al.. 2019. Actin-dependent endosomal receptor recycling.. Curr Opin Cell Biol 56:22-33 PMID: 30227382
- 7. Neumann U et al.. 2003. Protein transport in plant cells: in and out of the Golgi.. Ann Bot 92(2):167-80 PMID: 12876187
- 8. Schaub BE et al.. 2005. Analysis of protein transport to lysosomes.. Curr Protoc Cell Biol Chapter 15:15.8.1-15.8.12 PMID: 18228463
